Carter to lead Fusion Energy Division at Oak Ridge National Laboratory
A new nanoscience study led by a researcher at ORNL takes a big-picture look at how scientists study materials at the smallest scales.
It was reading about current nuclear discoveries in textbooks that first made Ken Engle want to work at a national lab. It was seeing the real-world impact of the isotopes produced at ORNL
Eric Myers of ORNL has been named a senior member of the Institute of Electrical and Electronics Engineers, effective June 21.
In a discovery aimed at accelerating the development of process-advantaged crops for jet biofuels, scientists at ORNL developed a capability to insert multiple genes into plants in a single step.
For the third year in a row, the Quantum Science Center held its signature workforce development event: a comprehensive summer school for students and early-career scientists designed to facilitate conversations and hands-on activities related to
ORNL’s electromagnetic isotope separator, or EMIS, made history in 2018 when it produced 500 milligrams of the rare isotope ruthenium-96, unavailable anywhere else in the world.
Growing up in suburban Upper East Tennessee, Layla Marshall didn’t see a lot of STEM opportunities for children.
“I like encouraging young people to get involved in the kinds of things I’ve been doing in my career,” said Marshall. “I like seeing the students achieve their goals. It’s fun to watch them get excited about learning new things and teaching the robot to do things that they didn’t know it could do until they tried it.”
Marshall herself has a passion for learning new things.
A study led by Oak Ridge National Laboratory researchers identifies a new potential application in quantum computing that could be part of the next computational revolution.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.